LICENSING

Build A2P2 into your organisation

A2P2 is licensed as an enterprise framework and protected platform. The objective is to establish a repeatable internal capability across R&D, materials science, quality and regulatory functions—not to sell an isolated calculation.

AVAILABLE TO ELIGIBLE ORGANISATIONS ONLY

ELIGIBILITY

A2P2 is licensed only to eligible organisations

Every licence begins with qualification. Eligibility is confirmed through a scientific and strategic assessment before commercial terms are discussed.

WHO IT IS FOR

Medical-device manufacturers

Biopharmaceutical and single-use-system organisations

Materials suppliers

Other regulated product companies

with recurring lifetime, stability or shelf-life decisions.

WHAT QUALIFICATION CONFIRMS

Product portfolio

Scientific need

Internal capability

Intended regulatory use

Commercial terms are discussed with qualified organisations only.

WHAT AN IMPLEMENTATION INCLUDES

A complete internal capability, not an isolated calculation

1

Annual rights to operate the patented A2P2 methodology within the agreed organisational scope.

2

Access to the protected A2P2 platform and applicable computational workflows.

3

A foundational programme using the licensee's lead device, material or interface.

4

Method transfer, laboratory implementation and team training.

5

Study-design, prediction and regulatory-output workflows.

6

Defined scientific governance, review and support.

7

A governed materials library that grows with each completed programme.

THE ADOPTION PATHWAY

From qualification to portfolio scale

ELIGIBILITY

1

Qualification

Confirm the product portfolio, scientific need, internal capability and intended regulatory use.

2

Foundational implementation

Apply A2P2 to one lead system, establish the governing mechanism and demonstrate the complete evidence pathway.

3

Method transfer

Train the relevant teams, establish laboratory procedures and embed governance.

4

Portfolio scale

Extend the framework across additional devices, materials and lifetime decisions.

TWO LICENSING PATHWAYS

Choose how A2P2 is used

PATHWAY 1

Enterprise licence

For organisations applying A2P2 internally across their own products, portfolios and regulatory submissions.

PATHWAY 2

Authorised service-provider licence

For qualified laboratories and technical-service organisations using A2P2 within governed programmes delivered to third-party customers. This pathway includes defined implementation, training, quality governance and customer-use rights.

External customer services, sublicensing and resale of A2P2-generated work are not included within an enterprise licence and require a separate commercial agreement.

COMMERCIAL STRUCTURE

Scoped to how A2P2 will be used

Licensing is scoped directly against organisational use, deployment breadth and implementation requirements. Commercial terms are discussed with qualified organisations following a scientific and strategic assessment.

Internal or customer-facing useBusiness unitsSitesAuthorised usersImplementation requirements

START A LICENSING DISCUSSION

Is your organisation eligible?

START A LICENSING DISCUSSIONEXPLORE THE PUBLIC DEMONSTRATION

Enquiries are reviewed for eligibility before any commercial discussion. nazli@gulsineltd.com